Share Price and Basic Stock Data
Last Updated: June 24, 2025, 8:13 pm
PEG Ratio | -3.65 |
---|
Competitors of Ganga Papers India Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Mohit Paper Mills Ltd | 44.4 Cr. | 31.7 | 50.0/25.4 | 6.83 | 36.4 | 0.00 % | 12.6 % | 13.6 % | 10.0 |
Gratex Industries Ltd | 6.03 Cr. | 19.9 | 28.4/14.2 | 86.1 | 12.0 | 0.00 % | 3.03 % | 1.96 % | 10.0 |
Ganga Papers India Ltd | 101 Cr. | 93.2 | 140/90.0 | 64.9 | 28.4 | 0.00 % | 6.21 % | 5.19 % | 10.0 |
Encode Packaging India Ltd | 3.67 Cr. | 11.6 | 19.0/10.9 | 10.3 | 0.00 % | 2.06 % | 2.12 % | 10.0 | |
Cella Space Ltd | 28.8 Cr. | 14.3 | 16.7/9.11 | 30.9 | 10.3 | 0.00 % | 10.7 % | % | 10.0 |
Industry Average | 851.25 Cr | 91.78 | 35.23 | 105.51 | 0.71% | 9.31% | 134.79% | 6.50 |
Quarterly Result
Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 77.29 | 86.29 | 71.15 | 67.60 | 72.90 | 62.16 | 56.94 | 64.01 | 62.39 | 65.73 | 57.32 | 70.47 | 64.17 |
Expenses | 74.45 | 83.37 | 68.12 | 65.76 | 71.52 | 60.48 | 55.38 | 62.38 | 60.55 | 64.28 | 55.84 | 69.20 | 62.42 |
Operating Profit | 2.84 | 2.92 | 3.03 | 1.84 | 1.38 | 1.68 | 1.56 | 1.63 | 1.84 | 1.45 | 1.48 | 1.27 | 1.75 |
OPM % | 3.67% | 3.38% | 4.26% | 2.72% | 1.89% | 2.70% | 2.74% | 2.55% | 2.95% | 2.21% | 2.58% | 1.80% | 2.73% |
Other Income | 0.31 | 0.04 | 0.06 | 0.05 | 0.03 | 0.04 | 0.10 | 0.04 | 0.14 | 0.03 | 0.03 | 0.03 | 0.28 |
Interest | 0.82 | 0.69 | 0.80 | 0.75 | 0.51 | 0.75 | 0.71 | 0.69 | 0.63 | 0.51 | 0.58 | 0.30 | 0.68 |
Depreciation | 0.53 | 0.52 | 0.52 | 0.55 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.55 | 0.55 | 0.55 | 0.55 |
Profit before tax | 1.80 | 1.75 | 1.77 | 0.59 | 0.34 | 0.41 | 0.39 | 0.42 | 0.79 | 0.42 | 0.38 | 0.45 | 0.80 |
Tax % | 15.00% | 24.57% | 28.25% | 25.42% | 32.35% | 24.39% | 30.77% | 26.19% | 25.32% | 26.19% | 10.53% | 35.56% | 22.50% |
Net Profit | 1.53 | 1.32 | 1.27 | 0.44 | 0.23 | 0.31 | 0.27 | 0.31 | 0.59 | 0.31 | 0.34 | 0.28 | 0.61 |
EPS in Rs | 1.42 | 1.22 | 1.18 | 0.41 | 0.21 | 0.29 | 0.25 | 0.29 | 0.55 | 0.29 | 0.32 | 0.26 | 0.57 |
Last Updated: May 31, 2025, 5:58 am
Below is a detailed analysis of the quarterly data for Ganga Papers India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 64.17 Cr.. The value appears to be declining and may need further review. It has decreased from 70.47 Cr. (Dec 2024) to 64.17 Cr., marking a decrease of 6.30 Cr..
- For Expenses, as of Mar 2025, the value is 62.42 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 69.20 Cr. (Dec 2024) to 62.42 Cr., marking a decrease of 6.78 Cr..
- For Operating Profit, as of Mar 2025, the value is 1.75 Cr.. The value appears strong and on an upward trend. It has increased from 1.27 Cr. (Dec 2024) to 1.75 Cr., marking an increase of 0.48 Cr..
- For OPM %, as of Mar 2025, the value is 2.73%. The value appears strong and on an upward trend. It has increased from 1.80% (Dec 2024) to 2.73%, marking an increase of 0.93%.
- For Other Income, as of Mar 2025, the value is 0.28 Cr.. The value appears strong and on an upward trend. It has increased from 0.03 Cr. (Dec 2024) to 0.28 Cr., marking an increase of 0.25 Cr..
- For Interest, as of Mar 2025, the value is 0.68 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.30 Cr. (Dec 2024) to 0.68 Cr., marking an increase of 0.38 Cr..
- For Depreciation, as of Mar 2025, the value is 0.55 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.55 Cr..
- For Profit before tax, as of Mar 2025, the value is 0.80 Cr.. The value appears strong and on an upward trend. It has increased from 0.45 Cr. (Dec 2024) to 0.80 Cr., marking an increase of 0.35 Cr..
- For Tax %, as of Mar 2025, the value is 22.50%. The value appears to be improving (decreasing) as expected. It has decreased from 35.56% (Dec 2024) to 22.50%, marking a decrease of 13.06%.
- For Net Profit, as of Mar 2025, the value is 0.61 Cr.. The value appears strong and on an upward trend. It has increased from 0.28 Cr. (Dec 2024) to 0.61 Cr., marking an increase of 0.33 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.57. The value appears strong and on an upward trend. It has increased from 0.26 (Dec 2024) to 0.57, marking an increase of 0.31.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 1:19 pm
Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 67 | 74 | 74 | 81 | 102 | 132 | 140 | 177 | 282 | 297 | 246 | 258 |
Expenses | 63 | 71 | 71 | 77 | 98 | 126 | 133 | 168 | 271 | 288 | 239 | 252 |
Operating Profit | 4 | 3 | 3 | 4 | 4 | 6 | 7 | 8 | 12 | 9 | 7 | 6 |
OPM % | 6% | 4% | 5% | 5% | 4% | 5% | 5% | 5% | 4% | 3% | 3% | 2% |
Other Income | 0 | 0 | 0 | 0 | -0 | 1 | 1 | 2 | 0 | 0 | 0 | 0 |
Interest | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 3 | 3 | 2 |
Depreciation | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Profit before tax | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 6 | 7 | 4 | 2 | 2 |
Tax % | 2% | 11% | 9% | -35% | 3% | 19% | 11% | 25% | 26% | 27% | 26% | 25% |
Net Profit | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 4 | 5 | 3 | 1 | 2 |
EPS in Rs | 1.20 | 0.95 | 0.98 | 1.61 | 1.38 | 1.52 | 1.72 | 3.83 | 4.97 | 3.01 | 1.37 | 1.44 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 0.00% | 0.00% | 100.00% | -50.00% | 100.00% | 0.00% | 100.00% | 25.00% | -40.00% | -66.67% | 100.00% |
Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | 100.00% | -150.00% | 150.00% | -100.00% | 100.00% | -75.00% | -65.00% | -26.67% | 166.67% |
Ganga Papers India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 13% |
5 Years: | 13% |
3 Years: | -3% |
TTM: | 5% |
Compounded Profit Growth | |
---|---|
10 Years: | 4% |
5 Years: | -4% |
3 Years: | -34% |
TTM: | 5% |
Stock Price CAGR | |
---|---|
10 Years: | 20% |
5 Years: | 36% |
3 Years: | 10% |
1 Year: | -9% |
Return on Equity | |
---|---|
10 Years: | 13% |
5 Years: | 13% |
3 Years: | 7% |
Last Year: | 5% |
Last Updated: Unknown
No data available for the Balance Sheet data table.
Cash Flow
Month | Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No data available for the Financial Efficiency data table.
No valid data available for the Shareholding
This stock is not held by any mutual fund.
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 1.44 | 1.37 | 3.02 | 4.96 | 3.83 |
Diluted EPS (Rs.) | 1.44 | 1.37 | 3.02 | 4.96 | 3.83 |
Cash EPS (Rs.) | 3.48 | 3.44 | 5.02 | 6.93 | 5.81 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 28.42 | 26.98 | 25.61 | 22.59 | 17.63 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 28.42 | 26.98 | 25.61 | 22.59 | 17.63 |
Revenue From Operations / Share (Rs.) | 238.85 | 227.55 | 276.16 | 254.83 | 163.69 |
PBDIT / Share (Rs.) | 5.86 | 6.51 | 8.67 | 11.08 | 9.37 |
PBIT / Share (Rs.) | 3.81 | 4.44 | 6.67 | 9.12 | 7.39 |
PBT / Share (Rs.) | 1.90 | 1.86 | 4.12 | 6.68 | 5.14 |
Net Profit / Share (Rs.) | 1.44 | 1.37 | 3.02 | 4.96 | 3.83 |
PBDIT Margin (%) | 2.45 | 2.86 | 3.13 | 4.34 | 5.72 |
PBIT Margin (%) | 1.59 | 1.95 | 2.41 | 3.57 | 4.51 |
PBT Margin (%) | 0.79 | 0.81 | 1.49 | 2.62 | 3.13 |
Net Profit Margin (%) | 0.60 | 0.60 | 1.09 | 1.94 | 2.34 |
Return on Networth / Equity (%) | 5.06 | 5.07 | 11.77 | 21.96 | 21.73 |
Return on Capital Employeed (%) | 12.59 | 15.25 | 22.59 | 25.09 | 21.81 |
Return On Assets (%) | 1.81 | 1.76 | 3.46 | 5.64 | 5.00 |
Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.08 | 0.53 | 0.83 |
Total Debt / Equity (X) | 1.16 | 1.27 | 1.61 | 1.56 | 1.81 |
Asset Turnover Ratio (%) | 3.04 | 2.76 | 3.16 | 3.10 | 2.35 |
Current Ratio (X) | 1.13 | 1.21 | 1.15 | 1.28 | 1.23 |
Quick Ratio (X) | 0.81 | 0.83 | 0.77 | 1.02 | 1.13 |
Inventory Turnover Ratio (X) | 11.36 | 8.57 | 12.06 | 24.09 | 16.61 |
Interest Coverage Ratio (X) | 3.06 | 2.53 | 3.40 | 4.54 | 4.15 |
Interest Coverage Ratio (Post Tax) (X) | 1.75 | 1.53 | 2.18 | 3.03 | 2.70 |
Enterprise Value (Cr.) | 139.94 | 142.35 | 115.59 | 99.17 | 61.65 |
EV / Net Operating Revenue (X) | 0.54 | 0.57 | 0.38 | 0.36 | 0.34 |
EV / EBITDA (X) | 22.14 | 20.26 | 12.36 | 8.29 | 6.10 |
MarketCap / Net Operating Revenue (X) | 0.40 | 0.43 | 0.24 | 0.25 | 0.19 |
Price / BV (X) | 3.44 | 3.67 | 2.67 | 2.90 | 1.79 |
Price / Net Operating Revenue (X) | 0.40 | 0.43 | 0.24 | 0.25 | 0.19 |
EarningsYield | 0.01 | 0.01 | 0.04 | 0.07 | 0.12 |
After reviewing the key financial ratios for Ganga Papers India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 1.44. This value is below the healthy minimum of 5. It has increased from 1.37 (Mar 23) to 1.44, marking an increase of 0.07.
- For Diluted EPS (Rs.), as of Mar 24, the value is 1.44. This value is below the healthy minimum of 5. It has increased from 1.37 (Mar 23) to 1.44, marking an increase of 0.07.
- For Cash EPS (Rs.), as of Mar 24, the value is 3.48. This value is within the healthy range. It has increased from 3.44 (Mar 23) to 3.48, marking an increase of 0.04.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 28.42. It has increased from 26.98 (Mar 23) to 28.42, marking an increase of 1.44.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 28.42. It has increased from 26.98 (Mar 23) to 28.42, marking an increase of 1.44.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 238.85. It has increased from 227.55 (Mar 23) to 238.85, marking an increase of 11.30.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 5.86. This value is within the healthy range. It has decreased from 6.51 (Mar 23) to 5.86, marking a decrease of 0.65.
- For PBIT / Share (Rs.), as of Mar 24, the value is 3.81. This value is within the healthy range. It has decreased from 4.44 (Mar 23) to 3.81, marking a decrease of 0.63.
- For PBT / Share (Rs.), as of Mar 24, the value is 1.90. This value is within the healthy range. It has increased from 1.86 (Mar 23) to 1.90, marking an increase of 0.04.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 1.44. This value is below the healthy minimum of 2. It has increased from 1.37 (Mar 23) to 1.44, marking an increase of 0.07.
- For PBDIT Margin (%), as of Mar 24, the value is 2.45. This value is below the healthy minimum of 10. It has decreased from 2.86 (Mar 23) to 2.45, marking a decrease of 0.41.
- For PBIT Margin (%), as of Mar 24, the value is 1.59. This value is below the healthy minimum of 10. It has decreased from 1.95 (Mar 23) to 1.59, marking a decrease of 0.36.
- For PBT Margin (%), as of Mar 24, the value is 0.79. This value is below the healthy minimum of 10. It has decreased from 0.81 (Mar 23) to 0.79, marking a decrease of 0.02.
- For Net Profit Margin (%), as of Mar 24, the value is 0.60. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.60.
- For Return on Networth / Equity (%), as of Mar 24, the value is 5.06. This value is below the healthy minimum of 15. It has decreased from 5.07 (Mar 23) to 5.06, marking a decrease of 0.01.
- For Return on Capital Employeed (%), as of Mar 24, the value is 12.59. This value is within the healthy range. It has decreased from 15.25 (Mar 23) to 12.59, marking a decrease of 2.66.
- For Return On Assets (%), as of Mar 24, the value is 1.81. This value is below the healthy minimum of 5. It has increased from 1.76 (Mar 23) to 1.81, marking an increase of 0.05.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.01.
- For Total Debt / Equity (X), as of Mar 24, the value is 1.16. This value exceeds the healthy maximum of 1. It has decreased from 1.27 (Mar 23) to 1.16, marking a decrease of 0.11.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 3.04. It has increased from 2.76 (Mar 23) to 3.04, marking an increase of 0.28.
- For Current Ratio (X), as of Mar 24, the value is 1.13. This value is below the healthy minimum of 1.5. It has decreased from 1.21 (Mar 23) to 1.13, marking a decrease of 0.08.
- For Quick Ratio (X), as of Mar 24, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 0.83 (Mar 23) to 0.81, marking a decrease of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 11.36. This value exceeds the healthy maximum of 8. It has increased from 8.57 (Mar 23) to 11.36, marking an increase of 2.79.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 3.06. This value is within the healthy range. It has increased from 2.53 (Mar 23) to 3.06, marking an increase of 0.53.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.75. This value is below the healthy minimum of 3. It has increased from 1.53 (Mar 23) to 1.75, marking an increase of 0.22.
- For Enterprise Value (Cr.), as of Mar 24, the value is 139.94. It has decreased from 142.35 (Mar 23) to 139.94, marking a decrease of 2.41.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.54. This value is below the healthy minimum of 1. It has decreased from 0.57 (Mar 23) to 0.54, marking a decrease of 0.03.
- For EV / EBITDA (X), as of Mar 24, the value is 22.14. This value exceeds the healthy maximum of 15. It has increased from 20.26 (Mar 23) to 22.14, marking an increase of 1.88.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.40. This value is below the healthy minimum of 1. It has decreased from 0.43 (Mar 23) to 0.40, marking a decrease of 0.03.
- For Price / BV (X), as of Mar 24, the value is 3.44. This value exceeds the healthy maximum of 3. It has decreased from 3.67 (Mar 23) to 3.44, marking a decrease of 0.23.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.40. This value is below the healthy minimum of 1. It has decreased from 0.43 (Mar 23) to 0.40, marking a decrease of 0.03.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ganga Papers India Ltd:
- Net Profit Margin: 0.6%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.59% (Industry Average ROCE: 9.31%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.06% (Industry Average ROE: 134.79%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.81
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 64.9 (Industry average Stock P/E: 35.23)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.16
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.6%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Paper & Paper Products | 241, Village Bebedohal, Tal. Maval, Pune Maharashtra 410506 | gangapapers@gmail.com http://www.gangapapers.in |
Management | |
---|---|
Name | Position Held |
Mr. Ramesh Kumar Chaudhary | Chairman & Non-Exe.Director |
Mr. Sandeep Kanoria | Executive & Managing Director |
Mr. Manish Kumar | Non Executive Director |
Mrs. Sadhana Kanoria | Non Executive Woman Director |
Mr. Ratan Kumar Singh | Independent Director |
Mr. Sanjeev Murarilal Jalan | Independent Director |
Mr. Anjani Kumar Agrawal | Independent Director |
Mr. Amit Kapoor | Independent Director |